Hyun-Ju Cho - Concepedia

Author

Hyun-Ju Cho

Chonnam National University Hwasun Hospital ORCID

Also Known As

Cho, Hyun-Ju, HYUN-JU CHO, HYUN‐JU CHO, Hyun-Ju Cho, Hyunju CHO, Hyunju Cho, Hyun‐ju Cho, Jae-Geun Lee

Publications

916

Citations

H-Index

Concepts

All Affiliations

Chonnam National University Hwasun Hospital Seoul National University Chonnam National University Chonnam National University Hospital Seoul National University Hospital

About

Hyun-Ju Cho is an author at Chonnam National University Hwasun Hospital specializing in medicine, lung cancer, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	164
2	Arts	1	1	24
3	Health Sciences	1	1	13
4	Natural Sciences	1	1	86
5	Biochemistry	1	1	86

Hyun-Ju Cho

Publications

742

Citations

H-Index

Page 1

	Year	Citations
Direct Conversion of Adult Skin Fibroblasts to Endothelial Cells by Defined Factors Jung‐Kyu Han, Sung-Hwan Chang, Hyun-Ju Cho, Circulation	2014	114
Phthalocyanine Tetrasulfonates Affect the Amyloid Formation and Cytotoxicity of α-Synuclein Eui-Nam Lee, Hyun-Ju Cho, Choong-Hwan Lee, Biochemistry Neurodegenerative DiseasesDisease AmyloidBiochemistryProtein AggregationNatural Sciences	2004	86
Methionine Sulfoxide Reductase B3-Targeted <i>In Utero</i> Gene Therapy Rescues Hearing Function in a Mouse Model of Congenital Sensorineural Hearing Loss Min-A Kim, Hyun-Ju Cho, Seung-Hyun Bae, Antioxidants and Redox Signaling	2015	79
β-Catenin Overexpression Augments Angiogenesis and Skeletal Muscle Regeneration Through Dual Mechanism of Vascular Endothelial Growth Factor–Mediated Endothelial Cell Proliferation and Progenitor Cell Mobilization Kwang‐Il Kim, Hyun-Ju Cho, Joo‐Yong Hahn, Arteriosclerosis Thrombosis and Vascular Biology	2005	73
A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2 Cheol‐Kyu Park, Hyun-Ju Cho, Yoo Duk Choi, Cancer Research and Treatment	2018	66
Efficacy of Gemcitabine in Patients with Non–Small Cell Lung Cancer According to Promoter Polymorphisms of the Ribonucleotide Reductase M1 Gene Soo-Ok Kim, Ju‐Yeon Jeong, Miran Kim, Clinical Cancer Research	2008	55
CD8<sup>+</sup> TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens Sung-Woo Lee, He Yun Choi, Gil-Woo Lee, Journal for ImmunoTherapy of Cancer	2021	32
Rac1 prevents cisplatin‐induced apoptosis through down‐regulation of p38 activation in NIH3T3 cells Hye Gwang Jeong, Hyun-Ju Cho, In Youb Chang, FEBS Letters	2002	28
A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain Hyun-Ju Cho, Hong-Joon Park, Mária Trexler, Journal of Molecular Medicine Developmental BiologyMedicineGeneticsStructural StabilityAudiology	2012	24
Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer Cheol‐Kyu Park, Hyung‐Joo Oh, Min‐Seok Kim, Translational Lung Cancer Research	2021	22

Page 1